Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

Abroad (travel likely)Recruiting

Conditions

Intracerebral Hemorrhage · Hemorrhagic Risk Conditions · Bleeding Disorders

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Lille, Lille, France
Contact: Study coordinator (Mélanie DANIEL, Dr) · melanie.daniel@hu-lille.fr · 03.20.44.59.62

Study leads

Mélanie Daniel, MD
Principal Investigator
University Hospital, Lille

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)

AF - Atrial Fibrillation · ICH - Intracerebral Hemorrhage

Abroad (travel likely)Recruiting

Hefei, China · Beijing, China

Evaluating a Prototype CT Scan for ICH Evacuation

Intracerebral Hemorrhage

Abroad (travel likely)Recruiting

New York, United States

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Intracerebral Hemorrhage

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Baldwin Park, United States

Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage

Intracerebral Hemorrhage

Abroad (travel likely)Recruiting

Wuhu, China · Beijing, China